Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging.

BACKGROUND AND PURPOSE Studies of intradermal melanoma xenografts have suggested that dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) may be a useful method for assessing the extent of hypoxia in tumors. Because the microvascular network of tumors is influenced significantly by the site of growth, we challenged this possibility in the present work by studying relationships between DCE-MRI-derived parameters and hypoxia in intramuscular melanoma xenografts. MATERIALS AND METHODS Intramuscular R-18, U-25, and V-27 tumors were subjected to DCE-MRI and measurement of the fraction of radiobiologically hypoxic cells (HF(Rad)). Parametric images of K(trans) and v(e) were produced by pharmacokinetic analysis, and K(trans) and v(e) were related to HF(Rad) in individual tumors. RESULTS K(trans) decreased with increasing HF(Rad). The correlations between K(trans) and HF(Rad) were similar for the three tumor lines and were highly significant (P<0.00001). There was no correlation between v(e) and HF(Rad). However, v(e) decreased significantly with increasing cell survival after single dose irradiation. CONCLUSION Intramuscular melanoma xenografts show similar inverse correlations between K(trans) and HF(Rad) as intradermal tumors, which support the current clinical attempts to establish DCE-MRI as a method for detecting hypoxia and defining therapeutic targets in tumors.

[1]  M. Alber,et al.  Imaging oxygenation of human tumours , 2006, European Radiology.

[2]  Nicholar E. Hagemeier,et al.  A quantitative analysis of vascularization and perfusion of human glioma xenografts at different implantation sites. , 1999, Microvascular research.

[3]  J P Logue,et al.  Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[5]  E. Rofstad,et al.  Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast‐enhanced magnetic resonance imaging , 2005, Journal of magnetic resonance imaging : JMRI.

[6]  N. Hylton Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  E. Rofstad,et al.  Magnetic resonance imaging of tumor necrosis , 2011, Acta oncologica.

[8]  P. Vaupel,et al.  Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.

[9]  S. Rockwell,et al.  Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. , 1984, International journal of radiation oncology, biology, physics.

[10]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[11]  E. Rofstad,et al.  Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia. , 2010, Neoplasia.

[12]  E. Rofstad,et al.  Assessment of Fraction of Hypoxic Cells in Human Tumor Xenografts with Necrotic Regions by Dynamic Contrast-Enhanced MRI , 2008, Radiation research.

[13]  E. Rofstad,et al.  Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. , 1999, International journal of radiation biology.

[14]  Dag Rune Olsen,et al.  Strategies for biologic image-guided dose escalation: a review. , 2009, International journal of radiation oncology, biology, physics.

[15]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[16]  E. Rofstad,et al.  Dynamic contrast‐enhanced‐MRI of tumor hypoxia , 2012, Magnetic resonance in medicine.

[17]  E. Rofstad,et al.  Quantitative assessment of hypoxia in melanoma xenografts by dynamic contrast-enhanced magnetic resonance imaging: intradermal versus intramuscular tumors. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  B. Fenton,et al.  Should direct measurements of tumor oxygenation relate to the radiobiological hypoxic fraction of a tumor? , 1995, International journal of radiation oncology, biology, physics.

[19]  M. Dewhirst,et al.  Tumor oxygenation: a matter of supply and demand. , 1996, Anticancer research.

[20]  E. Rofstad,et al.  Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.

[21]  E. Rofstad,et al.  Fluctuations in tumor blood perfusion assessed by dynamic contrast‐enhanced MRI , 2007, Magnetic resonance in medicine.

[22]  P. López-Larrubia,et al.  Imaging tumor hypoxia by magnetic resonance methods , 2011, NMR in Biomedicine.

[23]  Kristine Gulliksrud,et al.  Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  P. Jakob,et al.  Correlating quantitative MR measurements of standardized tumor lines with histological parameters and tumor control dose. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  E. Rofstad,et al.  Assessment of tumor blood perfusion by high‐resolution dynamic contrast‐enhanced MRI: A preclinical study of human melanoma xenografts , 2004, Magnetic resonance in medicine.

[26]  E. Rofstad,et al.  Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging. , 2009, International journal of radiation oncology, biology, physics.

[27]  E. Rofstad,et al.  Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  Evis Sala,et al.  Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. , 2007, The Lancet. Oncology.

[29]  Jian Z. Wang,et al.  Predicting Control of Primary Tumor and Survival by DCE MRI During Early Therapy in Cervical Cancer , 2009, Investigative radiology.

[30]  E. Rofstad,et al.  Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling. , 2008, Magnetic resonance imaging.

[31]  Kristine Gulliksrud,et al.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Tumors: Preclinical Validation of Parametric Images , 2009, Radiation research.

[32]  M V Knopp,et al.  Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  M Recht,et al.  Method for the quantitative assessment of contrast agent uptake in dynamic contrast‐enhanced MRI , 1994, Magnetic resonance in medicine.

[34]  H Lyng,et al.  Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd‐DTPA‐enhanced MR imaging , 2001, Journal of magnetic resonance imaging : JMRI.

[35]  F. Gilbert,et al.  A combined pharmacokinetic and radiologic assessment of dynamic contrast-enhanced magnetic resonance imaging predicts response to chemoradiation in locally advanced cervical cancer. , 2009, International journal of radiation oncology, biology, physics.

[36]  D. Siemann,et al.  Utility of 19F MRS detection of the hypoxic cell marker EF5 to assess cellular hypoxia in solid tumors. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  James L Tatum,et al.  Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy , 2006, International journal of radiation biology.

[38]  R. Hermans Estimation of tumour oxygenation levels with dynamic contrast-enhanced magnetic resonance imaging. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  Daniela Thorwarth,et al.  Implementation of hypoxia imaging into treatment planning and delivery. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.